GERN
Geron Corporation
NASDAQ · Healthcare · Biotechnology · US
$1.57
+3.97%Leverage
- Debt / equity
- 0.56x
- Net debt / equity
- 0.27x
- Debt / assets
- 0.24x
- Debt / EBITDA
- -2.93x
- Net debt / EBITDA
- -1.43x
Liquidity & coverage
- Current ratio
- 6.92x
- Quick ratio
- 5.16x
- Cash ratio
- 4.28x
- Interest coverage
- -1.24x
- EBITDA / interest
- -1.38x
- Working capital
- $416.0M
Cash & dividend
- FCF / debt
- -0.94x
- Cash flow / debt
- -0.94x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026